Literature DB >> 23361479

Imaging of the pituitary and parasellar region.

Joshua W Lucas1, Gabriel Zada.   

Abstract

The sellar and parasellar region is anatomically complex and encompasses many important vascular, endocrine, and neural structures. Pathology that arises within this region is often similarly complex, and requires a combination of endocrinologic, ophthalmologic, and neurologic examinations combined with advanced neuroimaging modalities. Magnetic resonance imaging (MRI) has become the gold standard for characterization of sellar and parasellar pathology due to the high contrast and detail it provides. Computed tomography (CT) allows for identification of bony involvement of lesions and also the general bony anatomy of the sellar region. Both modalities combined allow for complete characterization of sellar and parasellar pathology. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Mesh:

Year:  2013        PMID: 23361479     DOI: 10.1055/s-0032-1331806

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  4 in total

1.  MR imaging analysis of posterior pituitary in patients with pituitary adenoma.

Authors:  Shousen Wang; Kunzhe Lin; Deyong Xiao; Lin Zhao; Yong Qin; Liangfeng Wei
Journal:  Int J Clin Exp Med       Date:  2015-05-15

2.  The neuroimaging features of Rathke's cleft cysts in children with endocrine-related diseases.

Authors:  Altan Güneş; Serra Özbal Güneş
Journal:  Diagn Interv Radiol       Date:  2020-01       Impact factor: 2.630

3.  Factors Affecting Visual Field Outcome Post-Surgery in Sellar Region Tumors: Retrospective Study.

Authors:  Prabu Rau Sriram; Puliventhan Sellamuthu; Abdul Rahman Izani Ghani
Journal:  Malays J Med Sci       Date:  2017-12-29

4.  The Relationship Between Posterior Pituitary Bright Spot on Magnetic Resonance Imaging (MRI) and Postoperative Diabetes Insipidus for Pituitary Adenoma Patients.

Authors:  Shousen Wang; Kunzhe Lin; Deyong Xiao; Liangfeng Wei; Lin Zhao
Journal:  Med Sci Monit       Date:  2018-09-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.